chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pounding headache; sore throat; felt feverish; feel achy; fatigued; diagnosed her with shingles; blisters around her mouth and face on the RIGHT side; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (severe case of Chickenpox at age 14 years). Previously administered products included Shingrix (received Shingrix on an unknown date).   On 18th June 2021 02:00, the patient received the 2nd dose of Shingrix (intramuscular). In June 2021, 4 hrs after receiving Shingrix, the patient experienced shingles and blister. On 18th June 2021, the patient experienced pain and fatigue. On 19th June 2021, the patient experienced headache, sore throat and fever. On an unknown date, the outcome of the shingles, pain, fatigue, headache, sore throat, fever and blister were not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain, fatigue, headache, sore throat, fever and blister to be related to Shingrix.  Additional details provided as follows: The patient received her Shingrix vaccine and after 4 hours patient experienced pain and fatigue.On the next day she experienced pounding headache and sore throat.On that evening the patient reported that she felt feverish. On 20 June 2021,the patient reported that she experienced blisters around her mouth and face on the right side. The patient reported that she went to Health care professional on 23rd june and diagnosed with shingles. The patient reported her Health care professional did not want her to take any steroids or antiviral medications to not disturb the Shingrix vaccine. The patient reported that she will go back to the HCP next week for a follow-up.Her Health care professional is hoping for a spontaneous recovery due to the Shingrix vaccine. The patient reported that at the time of reporting none of the symptoms have resolved completely. The patient reported a severe case of Chickenpox at age 14, but never had shingle before now.  Patient did not gave permission to contact Health care professional. Did not consented to followup.
Towards the end of December, patient started feeling generalized pain in her fingers. 50 yo female childbirth educator presents to Occupational Health with c/o "pain in fingers after receiving a shot, worsening with movement." She stated, symptoms occurred 30 days after giving the flu vaccine. On 11/22/13, employee was convinced to obtain the flu vaccine (Flublok) after being exempt in 2012 due to pain she experienced in her finger she attributed to receiving the flu vaccine in 2011. She stated she experiences an "arthritic - like" reaction everytime she has received the flu vaccine. She has received the flu vaccine 3 time. The only time she has not experienced this "arthritic - like" reaction was in 2012 when she did not receive the vaccine.
Covid +.  Symptoms started 2/22/23.  Tested positive 2/24/23
Menstrual period began exactly one week early. This occurred 23 days after second vaccine shot. Irregular period is abnormal for me.
After receiving the second dose of the vaccine,  my husband experienced left arm pain which he thought was from the injection. About a week later, the pain got worse and moved toward his chest. It got so bad, he had to be taken by ambulance to the hospital to find out he had been having a heart attack. He spent nearly three weeks in the hospital before he died on 4/15/21
A 34 year old female patient experienced nausea, abdominal cramps, sore throat, hoarseness, fatigue, muscle soreness, weakness and headache after receiving RabAvert (lot number 336011, expiration date 03/07) for pre exposure prophylaxis. RabAvert 1ml was received via intramuscular injection in the deltoid on 09/16/04 and 09/23/04. The patient had no past medical history, was on no concomitant medication and had no known allergies. The patient had no adverse reactions to her first dose of RabAvert on 09/24/04, the day after her second dose, she experienced nausea, abdominal cramps, sore throat, hoarseness, fatigue, muscle soreness, weakness and headache. Her physician treated her with oral prednisone. She was cleared by the occupational health clinic to return to work on 10/07/04. She was seen again in the clinic on 10/14/04 and the events were completely resolved. The patients' third dose of RabAvert, due between 10/07/04 and 10/14/04, was held until further occupational health assessment, scheduled for 10/28/04.
Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: pt complained about numbness of his left facial area, which pt described as if he's having a "dental procedure." Monitored pt for prolonged time and released after pt claimed the sensation came back.
Shortly after Gardasil (HPV) vaccine was given in the right shoulder, she developed heaviness in that arm. At work she could only work with her left arm. About an hour later she started to develop large "bumps" al over her right arm which became itchy and painful. She later bought Benadryl but said she still could hardly sleep. She was seen in the office the next day. She had large erythematous nodules all over her right arm and forearm only. Not anywhere else. They were pruritic. She was given an Epinephrine injection subcutaneously immediately and prescribed hydroxyzine orally and triamcinolone 0.1% cream topically. She was instructed to go to the Emergency room if she developed signs of respiratory difficulty or if any of the symptoms worsened.
adverse reaction was like having covid again; Fever of only 101.5; aches; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (adverse reaction was like having covid again), PYREXIA (Fever of only 101.5) and MYALGIA (aches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LOVASTATIN for Cholesterol, TELMISARTAN for Hypertension.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced COVID-19 (adverse reaction was like having covid again), PYREXIA (Fever of only 101.5) and MYALGIA (aches). On 28-Feb-2021, COVID-19 (adverse reaction was like having covid again), PYREXIA (Fever of only 101.5) and MYALGIA (aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was unknown   This case was linked to MOD-2021-017691 (Patient Link).
The evening after my 2nd covid vaccine, my jaw and gums on the left side of my face became aching badly to where I could not hardly get any sleep. My gums were  swollen on the left and bleeding toward the back molars. The pain and swelling decreased each day and gone after a few days. The following month I had Tinnitus which was mainly my notable in my left ear.  The tinnitus has not ended to this date. I did not see the doctor for the pain and swelling, but I did see the doctor for the tinnitus.
Woke 4-8-06 with hives on legs. Gave Benadryl, hives on legs again 4/9/06 and few on face. Relieved with Benadryl.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Mar2021 as dose 1, single (Lot number: EN6206), in left arm and on 01Apr2021 as dose 2, single (Lot number: ER8730) at the age of 57 years, in left arm for Covid-19 immunisation; CoviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 08Nov2021 as dose 3 (booster) single (Lot number: 033F214), in left arm for Covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: MUCINEX, start date: 28Apr2022, stop date: 08May2022; SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE], start date: 28Apr2022, stop date: 08May2022. The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: tested positive antigen and PCR; Positive; Positive, notes: tested positive antigen and PCR. Therapeutic measures were taken as a result of Covid-19. Clinical Course: stuffy nose started on Covid day 13. tested positive antigen and PCR.
patient fainted about 5 minutes after getting first dose of Pfizer vaccine and fell and hit the back of head. Patient regained consciousness shortly after and was taken to hospital for observation due to hitting the head.
pt recv vax 8MAY95 10Am & awoke 130AM felt bad all over aching like the flu; called in sick for work; spoke w/MD instructed to visit w/MD
headache; muscle pain; joint pain; moderate fatigue; Mild temperature of 99.0 F; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3247; expiry date: unknown) via an unspecified route of administration in the left arm, on 21Jan2021 at 17:00, at a single dose, for COVID-19 immunization. Medical history included chronic migraine and polycystic ovaries (PCOS). Concomitant medications included drospirenone, ethinylestradiol (NIKKI), eletriptan hydrobromide (RELPAX), naproxen sodium (ALEVE), and unspecified prenatal vitamins. The patient previously took oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET) and morphine and experienced allergies. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the workplace clinic. On 21Jan2021, the patient experienced mild temperature of 99.0 F. On 22Jan2021 at 14:00, the patient experienced headache, muscle and joint pain, and moderate fatigue. The events were considered non-serious. The patient did not receive treatment for the events. Outcome of the events was recovering.
Rash at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number NP33H, expiry date 8th April 2022) for prophylaxis.   On 28th August 2020, the patient received the 1st dose of Shingrix. On 28th August 2020, immediately after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was recovered/resolved.   It was unknown if the reporter considered the injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. Pharmacist stated that a patient received the first dose of Shingrix and developed a rash at the injection site soon after.  The patient did not report it right away, and the rash was now resolved.  She was inquiring should she receive the 2nd dose. The reporter consented to follow up. The case had been linked with US2020191564 same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020191564:same reporter
Chills, pouring sweats, aches, fatigue. Extreme 24 hours, lingering additional 48 hours
10/25/2021 I began to cough up phlegm, that lasted for that day. The next day on 10/26/2021, I experienced body aches, headache, sinus drainage, fatigue, fever, which lasted until 10/28/2021. On the 28th of October I had no taste or smell. I still do not have my sense of smell back, but I am just now getting my taste back as of 11/02/2021.
Patient received vaccine for which we have no stability data. The vaccine would be stable up to noon on 6/22/2022, and she received at 2pm on 6/24/2022. This was due to a storage error in which the vaccine Tris-Sucrose formulation was stored in the freezer upon receipt from the freezer when it should have been stored in the refrigerator.
Grandmother called stating on 2/29/00 in the evening, the pts right leg started to swell. It became very swollen on 3/1/00 and remains swollen on 3/2/00. States it is swollen from knee to her hip. States child is up and actively playing on the leg without difficulty. Seems sensitive and warm to touch. Pt has a low grade fever, no higher than 100 degrees. Recommended mother call MD and to give child ibuprofen and warm compresses to site affected.
Fogginess in my brain almost like a blanket over my brain and maybe a haziness; Making me slightly depressed; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021 the reporter stated he received the Pfizer-BioNTech Covid-19 vaccine and it feels like a blanket is over his brain and he feels like it is slight depression- like he wants to cry but can't. He stated he was doing okay, physically he feels fine but mentally he does not feel fine. 2 hours after the shot and his brain like a blanket, and it makes him feel a little depressed. This is the second day now. He thought he would feel better yesterday after he woke up but he did not. The outcome of the events was recovered on an unspecified date in 2021.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt recvd 1st dose of Hep B vax 21NOV90 & on 28NOV90 pt devel pruritic rash around the mouth & bleeding gums; tx w/oral suspension & topical bacitracin; pt recovered;
About 4 to 5 hours after receiving vaccine patient started to developed a rash throughout her body extending from the back of her neck, through her abdomen, to part of the leg. She described the rash as very itchy, red, and raised welts. She explained that it looks like "mosquito bites" throughout her body.
Fever, vesicles appeared 3 weeks/1 day after immunization, fever up to 103; vesicles broke, scabbed over, child irritable.
Pt. mom notified this nurse on 1/18/17 at 16:30 that pt. arm that received injection was "swollen from shoulder down to elbow, warm to touch, and c/o itching." Mom states no fever, states pt denies pain or discomfort. 1/19/17 mom states "hasn't gotten worse but isn't better."
expired MENACTRA was accidentally given to a patient with no adverse event; Initial information received on 20-Apr-2022 regarding an unsolicited valid  non-serious case received from a other health care professional.  This case involves a 11 years old female patient who experienced expired menactra was accidentally given to a patient with no adverse event while receiving Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 20-Apr-2022, the patient received a 0.5 ml of suspect Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra] (frequency: once) (lot number : U6921AA,Expiration date:17-04-2022) (route, administration site :unknown) for immunization.  On 20-APR-2022 the patient developed  non-serious  event expired menactra was accidentally given to a patient with no adverse event (expired product administered) following the administration of Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra] .  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (expired MENACTRA was accidentally given to a patient with no adverse event).  At time of reporting, the outcome was Unknown for the event expired menactra was accidentally given to a patient with no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Administrative deviation only; no adverse event resulted from deviation. This patient received a  mixes series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer-box #4 reflects the date of the second dose).The decision to administer a mixed series to the patient was due to an " exceptional circumstance" stemming from the unavailability of the first vaccine product (Moderna) at  the time the second dose was due. We understand that although CDC provides considerations for a  mixed series in exceptional circumstances (such as a vaccine shortage, which is the case here), a mixed series is still considered an administration deviation that requires reporting.Note second vaccination date is listed.
Symptom onset about10 hours after dose: Fever (highest 102 F) & chills. Symptoms lasted all day. Resolved by the next morning. Soreness at injection site. Resolved within 4 days.
Pulse drop down; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Lot number: ER8737, Expiration Date: Jul2021) at the age of 69 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing), notes: Verbatim: Hypertension, When I was in my early 20s. Concomitant medication(s) included: CLONIDINE; ALISKIREN. Vaccination history included: Bnt162b2 (Dose number: 1, LOT number: EN6198, Expiration date: Jun2021), administration date: 12Mar2021, for Covid-19 Immunization. The following information was reported: PULSE ABNORMAL (non-serious), outcome "not recovered", described as "Pulse drop down". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient stated, "After both the Pfizer shot the second dose was 2 weeks ago today and she think the first week was okay and the second week her Pulse drop down to 68 but It meant to like 52, 50, 42, 45, and she was wandering was this connected, did she need to worry about or will it give away, her pulse has never been that." She took the clonidine, she didn't take Aliskiren last night because she was afraid to go to the sleep with pulse of 42.  No follow-up attempts are possible. No further information is expected.
Nausea and vomiting for approximately 8-10 hours; extreme fatigue for 36 hours; headache for approximately 24-36 hours
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 24-DEC-2018, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R019391 with expiration date 05-JUL-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
mom says pt ran mild fever 100 w/rash on trunk, spreading to arms/face;began 1 1/2hrs p/vax, necessitating MD visit 6DEC95-mom states MD said it was allergic rxn to shots;
Patient presented to pharmacy stating injection was given day prior and 3 hours after the injection the arm was red and painful upon touch near the injection site. Patient took TYLENOL and was doing ice packs. Now on second day the patient has pain to touch from the top of her arm near shoulder to the elbow on injection arm and is now red from about 2 inches below the injection site to the elbow. I instructed patient to take 2 BENADRYL tonight and continue with ice packs and I will reach out in the morning tomorrow to instruct further if needed.
1 hour post vaccine, started extreme fatigue and nodding off/sleeping which lasted 4 hours. Experienced chills 3 hours post vaccine which lasted 1 hour. The treatments I used were rest and warming myself.
SORE ARM, ARM NOT PAINFUL, FEELS DISCOMFORT AND AWARENESS, EXPERIENCES SORENESS; This spontaneous report received from a patient concerned a 70 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the patient experienced sore arm, arm not painful, feels discomfort and awareness, experiences soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore arm, arm not painful, feels discomfort and awareness, experiences soreness. This report was non-serious. This case, from the same reporter is linked to 20211049491  .
Stabbing pains in right hip, numbness upper right leg, pain in leg down to knee. After shot got high blood pressure.